Answers are grounded in this paper and cite their sources.
• Krill oil phospholipid/free fatty acid reduces triglycerides better than others forms. • Fish oil ethyl ester above 3000 mg effectively improves lipid profiles. • Fish oil triglyceride 2000–2900 mg benefits triglycerides and HDL cholesterol. • Fish oil re-esterified triacylglycerol 300–1900 mg reduces total and LDL cholesterol. The study aimed to compare the cardiovascular benefits of fish oil (FO) and krill oil (KO) in various molecular forms/variants. These included ethyl ester (EE), triglyceride (TG), re-esterified triacylglycerol (rTAG), phospholipid/free fatty acid (PL/FFA), high concentration phospholipid (HPL), low concentration phospholipid (LPL), and emulsion (EM), across diverse dosages. A network meta -analysis approach adhering to PRISMA guidelines was used. Sixty studies from databases including Embase, PubMed, ClinicalTrials.gov , ICTRP-WHO, and Cochrane (1993–2023) were analyzed with RStudio (PROSPERO ID: CRD42024502338). Key findings included KO-PL/FFA 2000–2900 mg effectively lowering triglycerides, FO-EE above 3000 mg reducing total cholesterol, FO-EE above 3000 mg and FO-TG below 2000 mg notably reducing low-density lipoprotein cholesterol, and FO-TG 2000–2900 mg improving high-density lipoprotein cholesterol. The study confirmed high reliability with no publication bias (p > 0.05, Egger’s test). In conclusion, KO-PL/FFA, FO-EE above 3000 mg, FO-TG 2000–2900 mg, and FO-rTAG 300–1900 mg effectively reduce cardiovascular risk factors.
No takes yet. Share an insight, caveat, or question.
Pham et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: